HERITAGE PHARMA
SCHOTT Pharma India marks a new chapter, building on its strong national presence and global capabilities
New identity reinforces the company’s focus on innovation, customer partnerships and pharmaceutical drug containment and delivery solutions
Quant Small Cap Fund exits ICICI Bank and 5 others, reduce stake in Zydus Wellness and 5 more in September
Quant Small Cap Fund exited ICICI Bank and five other stocks in September while trimming its holdings in six stocks, including Zydus Wellness. The fund also added six new stocks to its portfolio and increased its stake in 10 others, according to its monthly portfolio disclosure.
India, Bulgaria review bilateral ties; push for early India-EU FTA
India and Bulgaria have called for early implementation of the India-EU free trade agreement, saying it could significantly deepen bilateral economic ties. The two sides also reviewed cooperation in trade, investment, AI, space, defence, science and technology, while discussing wider regional and global issues.
For long-term investors who know and accept that more trouble might be on the way: 5 mid-cap stocks with upside potential of up to 32%
Headwinds continue to hit both the global and domestic markets. As the situation is unlikely to improve anytime soon, we may see a further erosion in stock prices in the coming weeks, even months. The thing to understand is this: Not all stock price drops are the same.
School assembly news headlines for August 28: Top India, world, sports and business updates
School Assembly News Headlines for August 28, 2026: India’s key developments include PM Modi’s upcoming Central Asia visit, preparations for the BRICS Summit, Nepal flood relief and new initiatives in Uttar Pradesh. International news focuses on Nepal floods and Dolly Parton’s death. Sports includes India’s cricket results and upcoming fixtures, while business news tracks markets, Nvidia and forex flows.
Govt renews MoU aimed at standardising medicinal plants used as traditional systems of medicine
India's government has renewed a three-year pact for standardizing medicinal plants. This initiative aims to harmonize quality standards with global benchmarks. The agreement builds upon the successful "One Herb, One Standard" concept launched earlier. It will develop uniform standards for single plant drugs across traditional systems. This collaboration strengthens India's position as a trusted global standard-setter.
- Go To Page 1
Torrent Pharma to buy controlling stake in JB Chemicals from KKR
Torrent Pharmaceuticals is set to acquire a 46.39% controlling stake in JB Chemicals and Pharmaceuticals from KKR for ₹11,917 crore, valuing JB Pharma at ₹25,689 crore. Following the acquisition, Torrent plans a merger, pending regulatory approvals, and will launch an open offer to public shareholders.
Torrent Pharma to acquire JB Chemicals at Rs 25,689 crore valuation
Torrent Pharma will acquire a controlling stake in JB Chemicals from KKR. The deal values JB Chemicals at Rs 25,689 crore. This merger will elevate Torrent to fifth position in the Indian pharmaceutical market. KKR is expected to gain a fivefold return on its 2020 investment. The combined entity aims for significant revenue and profitability growth.
Beyond TDP euphoria! Andhra-linked stocks that are worth buying for the long term
Stocks of companies linked to Andhra Pradesh surge post TDP victory, led by Heritage Foods and Aurobindo Pharma.
Stock market update: Nifty Pharma index advances 2.62% in an upbeat market
The Nifty Pharma index was trading 2.62 per cent up at 19090.75.
Stock market update: Nifty Pharma index falls 1.38%
The Nifty Pharma index closed 1.38 per cent down at 18603.15.
Stock market update: Nifty Pharma index falls 1.1% in a weak market
The Nifty Pharma index was trading 1.1 per cent down at 19108.4.
Corporate Radar: LIC Q4 results, JSW Steel's dividend, Tilaknagar's referential issue & more
LIC, Sun Pharma, IRCTC, Jindal Steel & Power, Delhivery, Jubilant FoodWorks and Aurobindo Pharma are among the companies which will announce their quarterly earnings today.
Stock market update: Nifty Pharma index advances 1.13% in an upbeat market
The Nifty Pharma index was trading 1.13 per cent up at 14128.7.
Board Meetings Today: Sun Pharma, Dabur India, Quess Corp, Ujjivan Financial Services and Heritage Foods
Aditya Birla Fashion, JP Associates and Vaibhav Global are slated to report their March quarter results on Wednesday.
PEs in talks for Emcure stake; promoters eye $2 billion valuation
JM Financial is advising the company for the stake sale.
Stock market update: 43 stocks hit 52-week lows on NSE
Among the stocks that touched their 52-week lows were Vodafone Idea and Zee Media.
Stock market update: 51 stocks hit 52-week lows on NSE
Domestic benchmark index NSE Nifty was trading 141.75 points up at 11,879.65.
Sun, Dr Reddy's among 7 Indian pharma majors sued in US for price rigging
The lawsuit widens a complaint of price collusion filed in 2016, which is still pending in US courts after being first investigated in 2014.
Pharma stocks crash after US lawsuit over price manipulations
The other generic makers named in the suit include Apotex, Teva, Heritage Pharma and Par Pharma.
Indian execs 'named' in US pharma case
The Indian generic makers named in the lawsuit are Aurobindo, Dr Reddy’s, Emcure, Glenmark, and Zydus.
US states sue 5 Indian generic drug makers over price cartelisation
The new lawsuit has also named some individual executives, including Rajiv Malik, president of Mylan, and Satish Mehta, MD of Emcure Pharma.
Top gainers and losers of Monday's session
In the Nifty50 pack, 35 stocks settled in green, while 16 in red.
Market Now: Nearly 40 stocks hit fresh 52-week highs today
In the Nifty50 pack, 40 stocks were trading in green, while 11 stocks were in red.
Drug companies can't rely on extreme price hikes in US: Glen Saldanha
Brokerage firms that were bullish on Indian drug makers are also feeling the jitters of the DOJ investigation and the threat of free market pricing that might dent the gold rush.
What class action suit against Taro means for Sun Pharma
Analysts were jittered by the DOJ investigation of drug pricing, with some brokerages cutting down the forecast for the Indian pharma sector.
US generics probe reveals startling detail of price fixing in Doxycycline and Glyburide
A Bloomberg report said two executives of Heritage Pharma – the US arm of Indian drug maker Emcure - are preparing to plead guilty to price-fixing charges while assuring cooperation with US prosecutors.
US subsidiary of Sun Pharma gets sub poena from US Justice Department
Two market analysts were of the view that the move may lead to a subdued sentimental outlook in the near term for Sun Pharma.
Load More
